Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Abbenante

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Biochemical Journal|January 6, 2000
Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15C N Shrimpton, G Abbenante, R A Lew, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 2000
A novel stable inhibitor of endopeptidases EC 3.4.24.15 and 3.4.24.16 potentiates bradykinin-induced hypotensionA I Smith, R A Lew, C N Shrimpton, et al.
Biochemical and Biophysical Research Communications|February 1, 2000
Inhibitors of beta-amyloid formation based on the beta-secretase cleavage siteG Abbenante, D M Kovacs, D L Leung, et al.
The Journal of Biological Chemistry|October 3, 2001
Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitorsD Leung, K Schroder, H White, et al.
Journal of Medicinal Chemistry|February 7, 2001
Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processingD P Fairlie, J D Tyndall, R C Reid, et al.
Biochemistry|July 1, 1999
Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 proteaseJ L Martin, J Begun, A Schindeler, et al.
Molecular and Biochemical Parasitology|February 13, 2001
Proteolysis of human hemoglobin by schistosome cathepsin DP J Brindley, B H Kalinna, J Y Wong, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Biochemical Journal|January 6, 2000
Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15C N Shrimpton, G Abbenante, R A Lew, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 2000
A novel stable inhibitor of endopeptidases EC 3.4.24.15 and 3.4.24.16 potentiates bradykinin-induced hypotensionA I Smith, R A Lew, C N Shrimpton, et al.
Biochemical and Biophysical Research Communications|February 1, 2000
Inhibitors of beta-amyloid formation based on the beta-secretase cleavage siteG Abbenante, D M Kovacs, D L Leung, et al.
The Journal of Biological Chemistry|October 3, 2001
Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitorsD Leung, K Schroder, H White, et al.
Journal of Medicinal Chemistry|February 7, 2001
Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processingD P Fairlie, J D Tyndall, R C Reid, et al.
Biochemistry|July 1, 1999
Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 proteaseJ L Martin, J Begun, A Schindeler, et al.
Molecular and Biochemical Parasitology|February 13, 2001
Proteolysis of human hemoglobin by schistosome cathepsin DP J Brindley, B H Kalinna, J Y Wong, et al.
Pageof 1